AusPAR Nubeqa

Australian Public Assessment Report

AusPAR

AusPAR Nubeqa [PDF, 2.42 MB]

AusPAR Nubeqa [Word, 4.62 MB]

Attachment Product information for Nubeqa [PDF, 444.35 KB]

Attachment Product information for Nubeqa [Word, 238.83 KB]

Device/Product Name

Nubeqa

Active ingredients

Darolutamide

AusPAR Date

30 September 2024

Published

9 October 2024

Submission Number

PM-2022-00878-1-4

Submission Type

Extension of indications

Decision

Approved